Type I Collagen
Type I collagen (Col-I), a fibrillary type collagen, is the most abundant collagen in the human body accounting for 90% of all collagen. It is the major protein component of the bone extracellular matrix and is commonly present in tissues where increased tensile strength is required, such as ligaments, tendons, menisci, skin, blood vessels, intervertebral discs, and cornea. The dominant isoform of type 1 collagen is a heterotrimer (i.e., a triple-helix structure) consisting of two pro-alpha1(I) chains and a pro-alpha2(I) chain. However, homotrimers of three pro-alpha1(I) chains, known to play a key role in wound healing, have been documented in fetal tissues, tumors, and some fibrotic lesions. In humans, pro-alpha1(I) and pro-alpha2(I) chains are transcribed and processed from COL1A1 and COL1A2 genes, respectively. The majority of type I collagen mutations result in bone and connective tissue disorders, in particular, osteogenesis imperfect types I-IV (brittle bone disease), Ehlers-Danlos syndrome classical type, Ehlers-Danlos syndrome type VIIA, idiopathic osteoporosis, and Caffey disease. Biomarkers for type I collagen are divided into two categories, degradation, and synthesis biomarkers. Col-I degradation biomarkers include Col-I neoepitope (C1M), C-terminal telopeptide of Col-I (CTX-I), and Col-I-derived crosslinked carboxy-terminal telopeptide (ICTP). Col-I synthesis biomarkers include carboxy-terminal propeptides of pro Col-I (PICP) and amino-terminal propeptides of pro Col-I (PINP).
Type I collagen has been visualized using a variety of techniques. Scanning and transmission electron microscopy provide high-resolution visualization of individual collagen fibers, but, is labor-intensive and expensive to perform. Western blot, IHC, IF and ELISA using type I collagen specific antibodies are more cost-effective alternatives, providing similar levels of sensitivity and are easily reproducible. In addition, single-cell RNA-sequencing analysis has been used to identify collagen I-producing cells and lineages in bone and bone marrow fractions.
Type I collagen has been visualized using a variety of techniques. Scanning and transmission electron microscopy provide high-resolution visualization of individual collagen fibers, but, is labor-intensive and expensive to perform. Western blot, IHC, IF and ELISA using type I collagen specific antibodies are more cost-effective alternatives, providing similar levels of sensitivity and are easily reproducible. In addition, single-cell RNA-sequencing analysis has been used to identify collagen I-producing cells and lineages in bone and bone marrow fractions.
Table 1. Type I collagen at-a-glance.
Marker ▲ ▼ | Chain Composition ▲ ▼ | Cell Types ▲ ▼ | Database Links ▲ ▼ |
Type I collagen | Two pro-alpha1(I) chains, One pro-alpha2(I) chain | Fibroblasts
Macrophages Osteoblasts Osteoclasts Chondrocytes | Gene ID: 1277 (type 1 collagen &alpha1), 1278 (type 1 collagen, &alpha2)
UniPort: P02452 (type 1 collagen, &alpha1), P08123 (type 1 collagen, &alpha2) OMIM: 120150 (type 1 collagen, &alpha1), 120160 (type 1 collagen, &alpha2) |
Table 2. Collagen antibodies.
Product ▲ ▼ | Clonality ▲ ▼ | Host ▲ ▼ | Reactivity ▲ ▼ | Conjugate ▲ ▼ | Application Dilutions ▲ ▼ | Unit Size ▲ ▼ | Cat No. ▲ ▼ |
Collagen I Antibody | Polyclonal | Rabbit | Human, Mouse, Rat | Unconjugated | IHC: 1:50∼1-100 IF: 1:100∼1-500 ELISA: 1:5000 | 50 µg | 8C0154 |
Collagen I α2 (Cleaved-Gly1102) Antibody | Polyclonal | Rabbit | Human | Unconjugated | WB: 1:500∼1:1000 IHC: 1:50∼1-100 IF: 1:100∼1:500 ELISA: 1:20000 | 50 µg | 8C12195 |
Collagen I α2 Antibody | Polyclonal | Rabbit | Human | Unconjugated | WB: 1:500∼1:1000 ELISA: 1:10000 | 50 µg | 8L0220 |
References
- Ricard-Blum S. (2011). The collagen family. Cold Spring Harbor perspectives in biology, 3(1), a004978. https://doi.org/10.1101/cshperspect.a004978
Original created on March 15, 2022, last updated on November 4, 2022
Tagged under: Collagen I, Col-I, Bone extracellular matrix, Osteogenesis imperfecta, Ehlers-Danlos syndrome, Anti-Collagen I, Collagen I antibodies, Pro-alpha1(I) chain, Pro-alpha2(I) chain